BIOMOTC MarketsView live quote
Investor Relations — info@biomolecularlife.com
Biomolecular LifeBiomolecular LifeHoldings Inc. · BIOM
Investor Relations

Investors & Newsroom

Biomolecular Life Holdings, Inc. is positioned at the intersection of longevity science, advanced wellness technology, precision nutrition, and premium consumer health. This is the company's hub for stock information, filings, and press releases.

BIOMTrading symbol
OTCOTC Markets
BIOMBiomolecular Life brand
Dec 31Fiscal year end
Full Quote on OTC MarketsLevel 2, trade history & security details
Company ProfileIssuer profile & disclosure — OTC Markets

Live price and chart provided by TradingView. Quotes for OTC securities may be delayed.

Newsroom

Press Releases

Official company announcements. Releases are also published to the company's OTC Markets news feed.

October 26, 2026Biomolecular Life Holdings, Inc. (OTC: BIOM) Announces Form 10 Effectiveness and Transition to SEC Reporting Company StatusThe Company’s Form 10 registration statement filed with the U.S. Securities and Exchange Commission has become effective, and the Company is transitioning to SEC reporting company status, subject to applicable periodic reporting and disclosure obligations under federal securities laws. The effectiveness of the Form 10 does not constitute SEC approval or endorsement of the Company, its business, or its securities.Read August 10, 2026Biomolecular Life Holdings, Inc. Enters Into Marketing Services and License Agreement With Biomolecular Life LLC, Taking On Brand and Marketing Management for the Biomolecular Life Supplement LineEffective August 7, 2026, the Company became the exclusive provider of advertising and promotion management for the Biomolecular Life supplement line for people and pets, in exchange for a marketing fee equal to 15% of net revenue from product sales. A supplemental disclosure statement describing the related party transaction was furnished through OTC Markets on August 10, 2026.Read July 28, 2026Biomolecular Life Holdings, Inc. Announces Completion of FINRA Name and Ticker Symbol Change to “BIOM” and Outlines Plan to Regain Fully Reporting Status Through Form 10 RegistrationThe name and ticker change from “VGLS” to “BIOM” became effective in the marketplace on July 15, 2026, and the Company is preparing a new Form 10 registration statement to return to fully reporting status with the SEC.Read
All News on OTC MarketsCompany news feed & release archive
Latest Release (PDF)October 26, 2026  ·  Form 10 Effectiveness and Transition to SEC Reporting Company Status
Filings & Disclosure

SEC & OTC Filings

All company filings can be verified directly with the regulators and OTC Markets. The links below are live. Historical SEC filings appear under the issuer's prior corporate names.

All SEC Filings (EDGAR)Full filing history — CIK 0001091326
OTC Markets DisclosureIssuer disclosure & reporting status

Recent Filings · Live from SEC EDGAR

Corporate Profile for Investors (PDF)Biomolecular Life overview — download
Investment Highlights

The case for Biomolecular Life

01

Longevity economy exposure

Operating across longevity, personalized wellness, nutraceuticals, preventive wellness, and companion-animal wellness.

02

Integrated ecosystem

Proprietary formulation science paired with premium nutritional supplements in one integrated platform.

03

Human & pet portfolio

A dual market spanning people and the companion animals they love.

04

Scalable model

Retail, licensing, and international distribution opportunities for proprietary formulations and products.

05

Premium positioning

Luxury wellness brand targeting the high end of a rapidly growing market.

06

R&D pipeline

Next-generation supplement formulations and AI-powered nutrition platforms.

Investor Relations

Contact Investor Relations

For investor inquiries, filings questions, and partnership opportunities.

info@biomolecularlife.com